Skip to main content
Fig. 2 | BMC Urology

Fig. 2

From: Silodosin improves functional consequences of lower urinary tract obstruction secondary to benign prostate hypertrophy, a proof of concept study in the spontaneously hypertensive rat supplemented with testosterone

Fig. 2

Cytometry parameters measured in conscious SHR supplemented by subcutaneous injections of testosterone that received by oral gavage once daily either vehicle (SHR-T) or silodosin at 0.1 mg/kg (SHR-T + silodosin) for 6 weeks. Data are expressed as mean ± SEM. *p < 0.05, Student’s t-test

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us